<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The following on prevalence and incidence of <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> in Barrett's esphophagus (BE) includes commentaries on the mechanisms of a potential protective effect of <z:chebi fb="0" ids="49200">proton pump inhibitors</z:chebi> (<z:chebi fb="4" ids="53266">PPIs</z:chebi>) on progression of BE to high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath>; evaluation of the role of <z:chebi fb="4" ids="53266">PPIs</z:chebi> in decreasing the risk of degeneration; the geographical variations of incidence of BE; the role of the nonmorphologic biomarkers; the relationship between length of BE and development of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>; the confounding factors in incidence rates of BE; the role of the increase of cell differentiation and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> induced by <z:chebi fb="4" ids="53266">PPIs</z:chebi> in the diminution of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk; the frequency of occult neoplastic foci and unsuspected <z:e sem="disease" ids="C0677898" disease_type="Neoplastic Process" abbrv="">invasive cancer</z:e> in surgical specimens; the influence on the indications of endoscopic therapy; the overestimation of regression in surgical series; attempts to evaluate the reasons for variations of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> incidence in the literature; and progress in screening and surveillance for BE </plain></SENT>
</text></document>